These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25870992)

  • 1. Two recent studies find Depo-Provera use increases HIV risk.
    Harper KN
    AIDS; 2015 Jun; 29(9):N1. PubMed ID: 25870992
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
    Wooltorton E
    CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913
    [No Abstract]   [Full Text] [Related]  

  • 4. Striae from DEPO-PROVERA injections.
    Harris D; Ridley CM
    Clin Exp Dermatol; 1996 Mar; 21(2):172. PubMed ID: 8759213
    [No Abstract]   [Full Text] [Related]  

  • 5. Depo Provera and bone density.
    Szarewski A; Mansour D; Hollingworth BA
    J Fam Plann Reprod Health Care; 2002 Apr; 28(2):94. PubMed ID: 12422861
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism.
    Hickey M; Marino JL; Tachedjian G
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):1-7. PubMed ID: 26761267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo-Provera contraceptive may increase risk of cardiovascular disease.
    Bosch X
    BMJ; 2002 Sep; 325(7363):513. PubMed ID: 12219755
    [No Abstract]   [Full Text] [Related]  

  • 8. Depo-Provera dilemmas.
    Cayley J
    Br J Fam Plann; 1998 Apr; 24(1):1. PubMed ID: 9719699
    [No Abstract]   [Full Text] [Related]  

  • 9. Depo Provera--irregular bleeding management.
    Hickey M; Paterson CM
    Br J Fam Plann; 2000 Apr; 26(2):117. PubMed ID: 10896462
    [No Abstract]   [Full Text] [Related]  

  • 10. Depo-Provera and bone density.
    Gbolade BA
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):7-11; quiz 11, 50. PubMed ID: 16259806
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinal fracture in a young Depo-Provera user.
    Searle ES
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):255. PubMed ID: 16105313
    [No Abstract]   [Full Text] [Related]  

  • 12. Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus.
    Guilbert ER; Kaunitz AM
    Contraception; 2009 Mar; 79(3):165-6. PubMed ID: 19185667
    [No Abstract]   [Full Text] [Related]  

  • 13. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera).
    Cromer BA
    Curr Opin Obstet Gynecol; 1999 Oct; 11(5):467-71. PubMed ID: 10526923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa.
    Tasker C; Pizutelli V; Lo Y; Ramratnam B; Roche NE; Chang TL
    AIDS; 2020 Apr; 34(5):729-735. PubMed ID: 31972606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study supports link between injectable hormonal contraceptive and HIV risk.
    Wise J
    BMJ; 2015 Jan; 350():h112. PubMed ID: 25575721
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute necrotic skin reaction to intramuscular Depo-Provera.
    Clark SM; Lanigan SW
    Br J Dermatol; 2000 Dec; 143(6):1356-7. PubMed ID: 11122072
    [No Abstract]   [Full Text] [Related]  

  • 20. End of the debate on hormonal contraception and HIV risk?
    Lancet Infect Dis; 2015 Feb; 15(2):131. PubMed ID: 25749056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.